Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-Ku, Tokyo, 105-8461, Japan.
Department of Gastrointestinal Surgery, Saku General Hospital Advanced Care Center, Nagano, 385-0051, Japan.
Surg Today. 2024 Mar;54(3):247-257. doi: 10.1007/s00595-023-02727-4. Epub 2023 Jul 24.
The preoperative platelet-to-lymphocyte ratio (PLR) has been reported as an important prognostic index for pancreatic ductal adenocarcinoma (PDAC); however, the significance of the postoperative (post-op) PLR for this disease has not been elucidated.
We analyzed data on 118 patients who underwent pancreaticoduodenectomy for pancreatic head PDAC, collected from a prospectively maintained database. The post-op PLR was obtained by dividing the platelet count after surgery by the lymphocyte count on post-op day (POD) 14. The patients were divided into two groups according to a post-op PLR of < 310 or ≥ 310. Survival data were analyzed.
A high post-op PLR was identified as a significant prognostic index on univariate analysis for disease-free survival (DFS) and overall survival (OS). The post-op PLR remained significant, along with tumor differentiation and adjuvant chemotherapy, on multivariate analysis for OS (hazard ratio = 2.077, 95% confidence interval: 1.220-3.537; p = 0.007). The post-op PLR was a significant independent prognostic index for poor DFS, along with tumor differentiation and lymphatic invasion, on multivariate analysis (hazard ratio = 1.678, 95% confidence interval: 1.056-2.667; p = 0.028).
The post-op PLR in patients with pancreatic head PDAC was an independent predictor of DFS and OS after elective resection.
术前血小板与淋巴细胞比值(PLR)已被报道为胰腺导管腺癌(PDAC)的重要预后指标;然而,术后(post-op)PLR 对此疾病的意义尚未阐明。
我们分析了 118 例接受胰头 PDAC 胰十二指肠切除术患者的数据,这些数据来自一个前瞻性维护的数据库。术后 PLR 通过将术后第 14 天的血小板计数除以淋巴细胞计数来获得。根据术后 PLR<310 或≥310,将患者分为两组。分析生存数据。
单因素分析显示,高术后 PLR 是无病生存(DFS)和总生存(OS)的显著预后指标。多因素分析显示,术后 PLR 与肿瘤分化和辅助化疗一起,对 OS 仍具有显著意义(风险比=2.077,95%置信区间:1.220-3.537;p=0.007)。术后 PLR 与肿瘤分化和淋巴浸润一起,是 DFS 不良的独立预后指标,多因素分析显示(风险比=1.678,95%置信区间:1.056-2.667;p=0.028)。
胰腺头 PDAC 患者的术后 PLR 是选择性切除术后 DFS 和 OS 的独立预测因子。